Amy is cofounder of Highlander Health, with a healthcare career marked by changemaking in organizations ranging from Flatiron Health to Duke University School of Medicine and Verily. Prior to Verily, Amy served as the principal deputy commissioner of the U.S. Food and Drug Administration from 2019-2021. Her board roles span public companies such as athenahealth and CareDx to private firms including insitro and Georgiamune. In addition to her standard setting and innovation work, Amy is a hematologist/oncologist, palliative medicine physician, and author of over 500 publications and counting.